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Abstract
Background: Multiple pathway databases are available that describe the human metabolic network and have
proven their usefulness in many applications, ranging from the analysis and interpretation of high-throughput data
to their use as a reference repository. However, so far the various human metabolic networks described by these
databases have not been systematically compared and contrasted, nor has the extent to which they differ been
quantified. For a researcher using these databases for particular analyses of human metabolism, it is crucial to
know the extent of the differences in content and their underlying causes. Moreover, the outcomes of such a
comparison are important for ongoing integration efforts.
Results: We compared the genes, EC numbers and reactions of five frequently used human metabolic pathway
databases. The overlap is surprisingly low, especially on reaction level, where the databases agree on 3% of the
6968 reactions they have combined. Even for the well-established tricarboxylic acid cycle the databases agree on
only 5 out of the 30 reactions in total. We identified the main causes for the lack of overlap. Importantly, the
databases are partly complementary. Other explanations include the number of steps a conversion is described in
and the number of possible alternative substrates listed. Missing metabolite identifiers and ambiguous names for
metabolites also affect the comparison.
Conclusions: Our results show that each of the five networks compared provides us with a valuable piece of the
puzzle of the complete reconstruction of the human metabolic network. To enable integration of the networks,
next to a need for standardizing the metabolite names and identifiers, the conceptual differences between the
databases should be resolved. Considerable manual intervention is required to reach the ultimate goal of a unified
and biologically accurate model for studying the systems biology of human metabolism. Our comparison provides
a stepping stone for such an endeavor.
Background
A detailed description of the human metabolic network
is essential for a better understanding of human health
and disease [1]. Several of the most prevalent diseases in
modern societies, such as cardiovascular disease, dia-
betes, and obesity have a strong metabolic component.
These multifactorial diseases involve hundreds of genes
and many developmental and environmental factors.
Therefore, network-based approaches are needed to
uncover the parts of the molecular mechanisms per-
turbed by disease [2] and to identify possible drug
targets. For example, metabolic networks are nowadays
routinely used for the systems-level interpretation of
high-throughput data, such as microarray gene expres-
sion profiles [3,4].
Over the past fifteen years several groups have con-
structed high-quality human (metabolic) pathway data-
bases that can be used in this endeavor [5-11]. One of
the first pathway databases was the Kyoto Encyclopedia
of Genes and Genomes (KEGG) database [8] that was
initiated to depart from the existing gene catalogs to
pathways. Another example is Reactome [6], which has
as one of its main goals to serve as a knowledgebase
that describes human biological processes and can be
used for computational analyses. The first fully compart-
mentalized, genome-scale in silico model of the human
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model forms a stepping stone for modeling human
metabolic phenotypes.
The various pathway databases available differ in a
number of ways and all have their own strengths and
weaknesses. For example, they have different solutions
for technical issues such as how the data is presented to
the user, how one can query the database [12,13], and
the exchange formats provided [12,14,15]. Several initia-
tives, such as BioWarehouse [16] and Pathway Com-
mons [17], have used a data warehouse approach to
resolve these differences. By bringing multiple databases
under one roof, a data warehouse can be used as “one-
stop shop” for answering most of the questions that the
source databases can handle, but via a uniform interface
[18]. Another type of difference is that the conceptuali-
zations used vary, for example, with respect to the defi-
nition of a pathway [12,19]. Furthermore, different
databases have taken different approaches in the recon-
struction process of the human metabolic network. The
reconstruction of the Edinburgh Human Metabolic Net-
work (EHMN) [9], for example, is based on a genome-
scale approach using genome annotation as a starting
point. Reactome on the other hand takes an incremental
approach, regularly adding new parts to its network, and
with reactions as basic units [6]. Also the manner and
level of curation may differ per database. For instance,
Recon 1 is completely manually curated using evidence
from literature and then fine-tuned and validated by
simulating 288 known metabolic functions in silico.
Most of the initial content of HumanCyc [11] was auto-
matically derived from both genome annotation and
MetaCyc, a multiorganism curated metabolic pathway
database, and only curated to a limited extent. Further
manual curation of HumanCyc resumed in 2009. Finally,
in the reconstruction process evidence from literature
may be interpreted differently by curators [1].
It may be apparent that the described differences will
have an effect on the metabolic networks defined by the
databases. However, so far the various metabolic net-
works available have not been systematically compared,
nor has the extent to which they differ been quantified.
For a researcher, e.g., a biomedical scientist who wants
t ou s et h e s ed a t a b a s e sa sar e f e r e n c er e p o s i t o r yo ra
bioinformatician who wants to perform a systems-level
analysis of human metabolism, it is crucial to know the
extent of the differences in content as well as their
underlying causes. The choice for a particular database
may, for example, influence the outcome of a computa-
tional analysis, as evidenced by diverging results for
methods that were applied to multiple metabolic path-
way databases [19-22]. Moreover, the sheer variety of
metabolic pathway databases is unsatisfactory and their
integration is desired. This has been recognized by
several groups and integration initiatives are currently
ongoing for various organisms [23]. This has already led
to the publication of consensus metabolic networks for
S. cerevisiae [24] and for the human pathogen S. typhi-
murium [25]. The results of a systematic comparison,
including the reasons for the differences, can be used as
a stepping stone for the reconciliation of human meta-
bolic networks.
We performed a systematic comparison of five fre-
quently used databases, each of which is based on a dif-
ferent approach towards reconstructing the human
metabolic network and built by an independent research
group: EHMN, Homo sapiens Recon 1 (referred to as
BiGG in the rest of the paper), HumanCyc, and the
metabolic subsets of KEGG and Reactome. We com-
pared the metabolic reactions, Enzyme Commission
(EC) numbers, enzyme encoding genes as well as combi-
nations of these three elements across the five selected
databases. We provide an overall analysis, but also com-
pare the tricarboxylic acid (TCA) cycle separately to see
in how far the databases agree on this classical meta-
bolic pathway. Our comparison allows us to identify the
parts the databases agree on and at the same time to
reveal conflicting information. Moreover, current recon-
structions of the human metabolic network are work in
progress and, therefore, still contain gaps as evidenced
by the regular updates of the various databases, reported
dead-end metabolites (Recon 1) [7], and listed missing
genes (HumanCyc). Our comparison provides a valuable
source of complementary information that can be used
to fill such knowledge gaps.
Our results show a surprisingly limited level of agree-
ment between the five databases and highlight the chal-
lenges to be met when integrating their contents into a
single metabolic network.
Results
For each of the five pathway databases, i.e., BiGG,
EHMN, HumanCyc, KEGG, and Reactome (Table 1), we
retrieved all metabolic reactions with their correspond-
ing genes, EC numbers, and pathways. Data was
imported in a relational database. The database content
statistics of the five databases (Table 2) already show
that there are notable differences in database size.
For each comparison we calculated the consensus,
defined as the overlap between the databases as a per-
centage of their union
consensus =
|CBiGG ∩ CEHMN ∩ CHumanCyc ∩ CKEGG ∩ CReactome|
|CBiGG ∪ CEHMN ∪ CHumanCyc ∪ CKEGG ∪ CReactome|
× 100%
where C is the set of entities (genes, EC numbers,
metabolites, reactions) under consideration. The consen-
sus is constrained by the smallest database for a specific
entity, which is in all cases Reactome. Therefore, we
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ferences in database size, the majority score, defined as
the number of entities that occurs in at least three out
of the five pathway databases as a percentage of their
union. To limit the impact of out-of-date identifiers and
EC numbers on our comparison, the ones that had been
transferred were replaced by their new ID/EC number
and otherwise they were not used in the comparison
(Additional file 1).
Comparison: genes
Although some reactions in the metabolic network may
take place spontaneously, most reactions are catalyzed
by an enzyme. In the first comparison we, therefore,
investigated the genes encoding for these enzymes by
comparing their Entrez Gene IDs. The consensus on
gene level is only 13% of the 3858 Entrez Gene IDs con-
tained in the union of all five databases (Table 3, Figure
1). The majority score shows that only 42% of all genes
can be found in at least three databases. There are 1139
genes that are present in only one of the databases,
representing 30% of the total.
We compared the gene ontology (GO) annotation of
the 510 genes in the consensus on gene level versus the
union of the remaining genes using FatiGO [26] to gain
a better understanding of the biological processes the
consensus genes are involved in. The set of consensus
genes is significantly enriched (adjusted P < 0.01) for
processes related to the generation of precursor metabo-
lites and energy, nucleotide metabolism, alcohol meta-
bolism, and cofactor metabolism (Additional file 2).
Comparison: EC numbers
The Nomenclature Committee of the International
Union of Biochemistry and Molecular Biology (NC-
IUBMB) classifies and names enzymes according to the
reaction they catalyze [27]. EC numbers are used as
the vocabulary to describe this classification. An EC
number consists of four numbers. The first three indi-
cate increasingly narrower classes of enzymatic func-
tions. The fourth number serves as a serial number
and defines the substrate specificity of the enzyme
[28]. Comparing EC numbers on the basis of only the
first three numbers (ignoring the last) thus gives a glo-
bal indication whether the databases agree on the
types of enzymatic functions involved in the human
metabolic network. There are 164 unique entries in
the union of all databases with a consensus of 51%.
For the remaining 49% the five databases do not agree.
For example, the group of peptidases present in the
union of the five databases is not part of the
consensus.
If we compare complete EC numbers, thus taking into
account the serial number that represents substrate spe-
cificity, the consensus decreases to 18% of the 1410 EC
numbers contained in the union (Table 3, Figure 1). Of
the total set of EC numbers 32% can only be found in a
single database, primarily HumanCyc.
Comparison: metabolites
Agreement on the metabolites that are part of the
metabolic network is a prerequisite for consensus
between databases on reaction level. Metabolites were
matched based on the KEGG Compound ID, if avail-
able for both metabolites. If the KEGG Compound ID
was absent, metabolites were matched on one of the
other four available metabolite identifiers (KEGG Gly-
can, ChEBI, PubChem Compound or CAS) or on
metabolite name, provided that also the chemical for-
mula matched. The consensus for the metabolites is
only 9% of the 4679 metabolites contained in the
Table 1 Overview of metabolic pathway databases used
Database Export formats used Version
a Downloaded from
BiGG Flat file, SBML 1 http://bigg.ucsd.edu/
EHMN Excel 2 http://www.ehmn.bioinformatics.ed.ac.uk/
HumanCyc Flat file 15.0 http://biocyc.org/download.shtml
KEGG Flat file, KGML 58 ftp://ftp.genome.jp/pub/kegg/
Reactome MySQL database 36 http://reactome.org/download/index.html
aDownloaded in the first week of May 2011
KGML: KEGG Markup Language; SBML: Systems Biology Markup Language.
Table 2 Pathway database content statistics
Number of
Database Genes EC numbers Metabolites Reactions
BiGG 1496 645 1485 2617
EHMN 2517 940 2676 3893
HumanCyc 3586 1215 1681 1785
KEGG 1535 726 1553 1635
Reactome 1159 356 984 1175
Genes: counts are based on the internal database identifiers and including
genes encoding for a component of a protein complex as separate entities.
EC numbers: only fully specified EC numbers are counted. Metabolites: counts
are based on the internal database identifiers and including instances of
metabolite classes for HumanCyc and members of sets for Reactome.
Reactions: if reactions only differ in direction and/or compartments they are
counted as one.
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21% of the metabolites.
Comparison: reactions
Reactions were considered to be the same if all sub-
strates and products matched (see above). As
expected, given the outcome of the metabolite com-
parison, the number of reactions included in all five
databases is small: consensus on reaction level equals
1% of 7758 reactions in the union of all five databases
(Table 3).
Reactions are not always balanced, especially with
respect to electrons (e
-), protons (H
+)a n dw a t e r( H 2O)
[29]. Therefore, we performed a second comparison
where reactions were not required to match with respect
to these three metabolites. The number of reactions in
the consensus nearly doubled to 199 reactions,
corresponding to 3% of the 6968 reactions in total. The
majority score for this reaction comparison equals 14%
(Table 3, Figure 1). Around one third of the 199 con-
sensus reactions are part of nucleotide metabolism or
cofactors and vitamins metabolism (Additional file 3).
This is in line with the results of the functional enrich-
ment analyses of the consensus genes.
We compared a relatively large number of pathway
databases, each restricting the consensus, which partly
explains the small overlap. If we only compare pairs of
databases, the overlap on reaction level increases sub-
stantially. The consensus of two databases ranges from
11%, when comparing EHMN and Reactome, to as
much as 28% when comparing EHMN and KEGG
(Additional file 4). The pairwise comparisons on gene,
EC number, and metabolite level also show a substantial
increase in overlap.
Table 3 Statistics of the pathway database comparison
Number of (percentage of union)
Genes EC numbers Metabolites Reactions Reactions (ignoring e
-,H
+,H 2O)
union 3858 1410 4679 7758 6968
consensus 510 (13%) 259 (18%) 400 (9%) 101 (1%) 199 (3%)
majority score 1636 (42%) 709 (50%) 967 (21%) 732 (9%) 1004 (14%)
Database Unique per database (percentage of union)
BiGG 45 (1%) 48 (3%) 528 (11%) 1441 (19%) 1250 (18%)
EHMN 128 (3%) 82 (6%) 1184 (25%) 2120 (27%) 1832 (26%)
HumanCyc 759 (20%) 294 (21%) 739 (16%) 1032 (13%) 905 (13%)
KEGG 63 (2%) 13 (1%) 282 (6%) 414 (5%) 348 (5%)
Reactome 144 (4%) 11 (1%) 406 (9%) 601 (8%) 539 (8%)
Total 1139 (30%) 448 (32%) 3139 (67%) 5608 (72%) 4874 (70%)
Genes: Entrez Gene IDs, including genes encoding for a component of a protein complex as separate entities. EC numbers: only fully specified EC numbers.
Metabolites: if two metabolites of one database both match the same metabolite in another database this is counted as one match. The first ‘Reactions’ column:
all reactions are considered. The second ‘Reactions’ column: reactions were not required to match on e
-,H
+ and/or H2O.
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Figure 1 Overlap between the five metabolic pathway databases for the global comparison. The dark green bars give the percentage of
entities (genes, EC numbers, metabolites and reactions) that are part of the consensus. The majority score is given by the combined
percentages of the dark green, light green (4 out of 5 databases agree) and yellow (3 out of 5) bars. The orange bars indicate the percentage of
entities that can only be found in 2 databases. The percentage of unique entities is indicated by the red bars. In matching the reactions we did
not take into account e
-,H
+ and H2O.
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So far, we only compared the databases on a single level.
We also investigated the consensus on two levels by
requiring the gene and the complete EC number to
match. For 35% of the 510 genes in the consensus, the
five databases also agree on all EC number(s) connected
to a gene. For 63% of the consensus genes the databases
agree on at least one EC number. The mismatches sug-
gest that the databases do not fully agree on the enzy-
matic activities that gene products can have.
If we require an exact match on all three levels - EC
number, gene, and reaction - then the five pathway
databases agree on the genes and EC numbers of 85 of
the 199 reactions in the consensus (when not taking
into account e
-,H
+ and H2O). For 44 reactions the data-
bases agree only on the EC number and for 25 reactions
only on the genes. For 24 consensus reactions there is
not a single EC number the databases agree on and not
a single gene for 9 reactions. The main reason (57 reac-
tions) that there is no agreement on all genes is because
one or more of the databases links additional genes to
the reaction in comparison to the other databases. See
Additional file 3 for a detailed summary of the consen-
sus reactions with their associated EC numbers, genes,
and pathways.
Comparison: TCA cycle
We also analyzed the well-known TCA cycle, already
described in 1938 by Krebs [30]. For this pathway we
expected a high agreement between the databases.
However, also for the TCA cycle the consensus on
reaction level is surprisingly low, although higher than
what was observed at database level. The databases
agree on 5 (17%) of the 30 reactions in total (Table 4
and Figure 2, see Additional files 5 and 6 for a break-
down per database). On gene level the consensus is
36% of 45 genes and on EC number level the consen-
sus is 30% of 20 EC numbers. For the five reactions in
the reaction consensus, the databases all agree on the
EC number and on at least one gene. Only for two
reactions (EC 1.1.1.41, EC 4.2.1.2) they agree on
exactly the same set of genes.
Analysis of differences between databases
The above results show that consensus between the five
databases is low on all levels compared. This is most
pronounced for the reactions. First, we use the TCA
cycle to illustrate a number of reasons for these differ-
ences. Next, we describe how this translates to the com-
parison at database level.
TCA Cycle
In what follows we present the main, sometimes over-
lapping, causes for lack of consensus at the reaction
level: (i) disagreement on pathway definition, (ii)d i f f e r -
ence in number of intermediate steps, (iii) a different
number of possible alternative substrates. In addition, it
is difficult to determine when databases refer to the
same metabolite. Missing and out-of-date gene identi-
fiers also hinder the comparison. Since genes and EC
numbers are tightly linked to reactions, most differences
on these two levels are caused by differences on the
reaction level. We conclude with additional causes for
lack of consensus for genes and EC numbers.
Pathway definition
The five pathway databases each have their own defini-
tion of which reactions are part of the pathway describ-
ing the TCA cycle. For example, in KEGG the
conversion of pyruvate into acetyl-CoA is included in
the TCA Cycle (Figure 2, purple area). In EHMN and
BiGG this conversion is part of the glycolysis/gluconeo-
genesis pathway and in the other two databases it is
part of a separate pathway. The differences in pathway
definition are further illustrated by several reactions that
a r en o ti nt h ec o n s e n s u so ft h eT C Ac y c l e ,b u ta r ep a r t
of the consensus at database level:
A. The reaction transforming oxaloacetate into phos-
phoenolpyruvate (EC 4.1.1.32 via GTP ® GDP, Fig-
ure 2). In general, this reaction, although tightly
linked to the TCA Cycle, is considered to be part of
gluconeogenesis [31]. However, KEGG includes this
reaction in the TCA cycle pathway. KEGG and
EHMN also mention the same conversion with an
alternative cosubstrate (EC 4.1.1.32 via ITP ® IDP).
The latter reaction is not part of the consensus at
database level.
B. The reaction converting citrate back to oxaloace-
tate (EC 2.3.3.8). This reaction is found in BiGG,
EHMN, and KEGG. According to Reactome the
reaction belongs to the pathway ‘Fatty Acyl-CoA
Biosynthesis’ and HumanCyc assigns it to ‘acetyl-
CoA biosynthesis (from citrate)’. Moreover, Reac-
tome also provides evidence that the reaction takes
place in the cytosol and not in the mitochondrion
where the TCA cycle takes place. Interestingly,
BiGG and EHMN also claim that the reaction does
Table 4 Statistics of the comparison of the TCA cycle
Number of (percentage of union)
Genes EC numbers Metabolites Reactions
Union 45 20 41 30
Consensus 16 (36%) 6 (30%) 18 (44%) 5 (17%)
Majority 23 (51%) 11 (55%) 25 (61%) 12 (40%)
Genes: including genes encoding for a component of a protein complex as
separate entities. EC numbers: fully specified EC numbers. Metabolites: several
metabolites were matched manually (see Materials and Methods). Reactions:
reactions where not required to match on H
+.
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include it in the TCA cycle nevertheless.
C. The reaction transforming succinyl-CoA into suc-
cinate via GDP ® GTP (EC 6.2.1.4). This reaction is
described in HumanCyc, but was not assigned to
any pathway.
D. The interconversion of NAD
+/NADPH and
NADH/NADP
+. Only Reactome includes this reac-
tion in the TCA Cycle, in the other four databases it
is part of pathways related to nicotinate and nicoti-
namide metabolism.
Differences in pathway definition explain why 14 of
the 30 reactions are not in the consensus (Additional
file 6).
Number of intermediate steps
Another explanation for the differences observed is that
the number of intermediate steps used to describe a
specific conversion varies. A typical example is the oxi-
dative decarboxylation of 2-oxoglutarate to succinyl-
CoA (2-oxoglutarate dehydrogenase complex). KEGG
describes this reaction in four steps. In BiGG, Human-
Cyc and Reactome the entire oxidative decarboxylation
is described in a single step. Interestingly, EHMN
describes it both in a single step as well as in three
steps.
The databases also disagree on the number of steps
for describing the conversion of citrate to isocitrate (EC
4.2.1.3). In BiGG and Reactome this is a single step, but
i tt a k e st w os t e p si nH u m a n C y ca n dK E G Gw i t hc i s -
aconitate as intermediate. Indeed, cis-aconitate has been
shown to be an intermediate in the conversion of citrate
into isocitrate [31,32]. EHMN includes both the single
and the two-step variant. Note that there is no auto-
mated way in which we could tell whether the difference
in the number of steps is because of a difference in the
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Figure 2 Comparison of the TCA cycle in five metabolic pathway databases. Map illustrating the (lack of) consensus for the TCA cycle.
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five databases agree on a specific entity (gene, EC number, reaction). We first matched reactions based on their metabolites. Genes and EC
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+ which was matched separately). ‘x’ denotes a missing EC number. Areas labeled A-D highlight the reactions that
are discussed in the running text as examples of differences caused by a disagreement on pathway definition.
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due to a disagreement on the number of steps needed
for that conversion. Differences in number of intermedi-
ate steps explain 14 mismatches on reaction level.
Number of alternative substrates
A third explanation for the observed differences is the
variation in the number of possible alternative substrates
listed. This is, for example, observed for the type of
nucleotide diphosphate as cosubstrate for the conversion
of succinyl-CoA to succinate. According to EHMN and
KEGG, not only ADP (EC 6.2.1.5) can be used, but also
IDP (EC 6.2.1.4). Differences caused by alternative sub-
strates explain six mismatches on reaction level.
Establishing identity
The comparison of the metabolites is hindered by the
difficulty of determining in an automated way when
databases refer to the same compound. For example, we
decided for three pairs of metabolites that the databases
are referring to the same metabolite, despite that the
databases linked different KEGG Compound IDs to
these metabolites (see Materials and Methods). The only
difference between these pairs, is that one is the enzyme
bound form of the metabolite, e.g., lipoamide-E (KEGG
Compound ID: C15972), and the other is indicated as
being unbound, e.g., lipoamide (KEGG Compound ID:
C00248). For a relatively small pathway like the TCA
Cycle, such highly similar compounds can be easily
identified manually, but on database level this is very
challenging.
Also out-of-date and missing identifiers influence the
comparison. Five unmatched genes from Reactome had
an Entrez Gene ID that had become obsolete and could
not be transferred to another entry. For a single gene in
H u m a n C y ct h e r ew e r en og e n ei d e n t i f i e r sa v a i l a b l ea t
all.
Additional explanations on gene and EC number level
On gene level, ten differences remain that are not
caused by differences on the reaction level or out-of-
date identifiers. Three genes (ACO1, IREB2, and
MDH1) encode for proteins that are not localized in the
mitochondrion, according to the UniProt annotation.
Since the TCA cycle takes place in the mitochondrion,
these may be annotation errors of the pathway data-
bases. In BiGG PDHX encodes for a component of the
2-oxoglutarate complex, but according to Entrez Gene it
encodes for a component of the similar, but different,
pyruvate dehydrogenase complex. The gene OGDHL,
which is found in three databases, is described by Entrez
Gene as ‘oxoglutarate dehydrogenase-like’,w h i c hr e f e r s
to the OGDH gene that is part of the consensus. For
two genes (LOC283398 and SUCLA2P1) in Reactome
the RefSeq status is ‘inferred’,w h i c hm a yb ear e a s o n
for the other databases to not include these genes. For
the other three genes (AMAC1, DHTKD1, MDH1B)
there is no clear explanation. Possibly these are incor-
rectly connected to the reactions of the TCA cycle.
For four EC numbers the differences on reaction level
do not explain why they are not part of the consensus.
All four are assigned to the reaction converting 2-oxo-
glutarate to succinyl-CoA by at least one of the data-
bases. Three of these EC numbers belong to the
individual components of the complex catalyzing the
reaction. BiGG only assigns one (EC 1.2.4.2) of these
three to the catalyst, EHMN assigns all three and
HumanCyc leaves the EC number blank. According to
IUBMB the EC number (EC 1.2.1.52) assigned by Reac-
tome belongs to the enzyme that can catalyze a similar
reaction, but with NADP
+/NADPH as cosubstrates
instead of NAD
+/NADH.
Database level
T h ee x p l a n a t i o n sw eg a v ef o rt h el a c ko fc o n s e n s u si n
the TCA cycle can be generalized to the comparisons
a td a t a b a s el e v e l .O n ee x c e p t i o ni st h ed i f f e r e n c ei n
pathway definition, as the subdivision of the network
in pathways no longer plays a role in the comparisons
on database level. However, a similar effect can be
observed due to differences in metabolic network
coverage.
Metabolic network coverage
All five databases are work in progress and, therefore,
do no yet fully cover the complete metabolic network.
As the database content statistics (Table 2) show, there
are large differences in the number of genes, EC num-
bers, and reactions contained in each database. On gene
and EC number level HumanCyc is largely a superset of
the other four databases and contains the highest num-
ber of unique entities on these two levels. EHMN has
the highest number of metabolites and reactions. This is
to a large extent explained by a set of 1100 transport
reactions and 1016 reactions in lipid metabolism con-
tained in EHMN, compared to 484 and 211, respec-
tively, in Reactome, for example. In general, the size
differences can be partly explained by the different cri-
teria the five databases have for including reactions in
their metabolic network. A difference in coverage could
also to some extent explain the large percentage of data
that is only found in one of the databases. For example,
there are 1139 unique genes and 4874 unique reactions
(Table 3).
To gain a better understanding of which parts of the
metabolic network are only described in a single data-
base, we compared the GO annotation of all 1139
unique genes versus the union of the remaining genes
using FatiGO (Additional file 2). The unique genes are
significantly enriched for terms related to ion transport,
protein metabolism like proteolysis, and to RNA meta-
bolism such as tRNA processing.
Stobbe et al. BMC Systems Biology 2011, 5:165
http://www.biomedcentral.com/1752-0509/5/165
Page 7 of 18For a more in-depth analysis of the coverage of the
individual databases, we compared for each database
separately its unique genes with the remaining genes
contained in the union (Additional file 2). HumanCyc
has the largest set of unique genes, which are signifi-
cantly enriched for terms related to, among others, ion
transport, protein metabolic processes like proteolysis,
and (t)RNA processing. Enriched terms for Reactome
include transport, protein catabolic processes, and regu-
lation of catalytic activity. As metabolic and non-meta-
bolic reactions in Reactome are intertwined, this might
be an indication that some non-metabolic reactions are
described in the metabolic pathways we selected.
EHMN only has few significant terms, which are related
to Golgi vesicle transport and budding. EHMN contains
the highest number of transport reactions, but 55% of
these are not linked to a gene and, therefore, do not
influence the GO analysis. BiGG and KEGG contain the
lowest number of unique genes and only BiGG has a
significantly enriched GO term, namely signal peptide
processing.
The GO enrichment analysis shows that the pathway
databases are partly complementary and include reactions
that are peripheral to metabolism proper, such as ion
transport and macromolecular reactions. On the other
hand, the genes contained in the majority of the databases
compared to the union of the remaining genes, proved to
be significantly enriched for many of what one could con-
sider to be core metabolic processes (Additional file 2):
nucleotide metabolism, carbohydrate metabolism, lipid
metabolism, and generation of energy, among others. One
might, therefore, conjecture that the consensus between
the databases would significantly increase by restricting
the comparison to core metabolic processes. For this pur-
pose, we first grouped the pathways from each of the data-
bases into categories using the KEGG hierarchy as a
guideline (see Materials and Methods, Additional file 7).
Next, we restricted the comparison to the following six
core metabolic categories: amino acid metabolism, carbo-
hydrate metabolism, energy metabolism, lipid metabolism,
metabolism of cofactors and vitamins, and nucleotide
metabolism. Reactions not part of any pathway could not
be assigned to a category and were therefore excluded.
Furthermore, we excluded macromolecular reactions, i.e.,
reactions in which at least one metabolite was labeled as
being a protein, for HumanCyc and Reactome. Also trans-
port reactions found in BiGG, EHMN, HumanCyc and
Reactome were excluded. The database content statistics
for this comparison of core metabolic processes are given
in Table 5. The consensus hardly changes for any of the
entities compared (Figure 3, Table 6). The majority score
for the gene comparison augmented considerably by 9%.
For the reaction comparison the majority score increased
by only 4%.
These results support the conclusion that the networks
are partly complementary, but also indicate that there
are additional reasons for the lack of overlap, which we
will describe below.
Number of intermediate steps
I nt h ec o m p a r i s o no ft h eT C Ac y c l ead i f f e r e n c ei nt h e
number of steps used to describe a specific metabolic
conversion could easily be identified manually. On data-
base level, however, this poses a considerable challenge
and would require very generic tools for network align-
ment. One indication that the problem is not restricted
to the TCA cycle is given by 64 reactions in BiGG for
which the comments in the SBML file indicate that the
reaction summarizes a conversion that actually consists
of several steps. For example, BiGG describes the break-
down of palmitoyl-CoA to octanoyl-CoA in a single
step. However, this is a simplification of four rounds of
beta oxidation, each round consisting of four separate
reactions. In KEGG the same conversion makes up a
large part of the ‘fatty acid metabolism’ pathway.
Number of alternative substrates
The number of reactions linked to one of the 259 con-
sensus EC numbers varies considerably across the data-
bases and equals 411 for Reactome, 441 for HumanCyc,
539 for BiGG, 582 for KEGG, and 942 for EHMN. A
possible explanation for a low number of reactions is
the use of a single generic reaction to model the broad
substrate specificity of an enzyme instead of explicitly
describing each specific reaction separately with the
same EC number. HumanCyc, for example, uses generic
metabolites, such as ‘an alcohol’, in 24% of the reactions
linked to an EC number from the consensus. The high
number of reactions in EHMN is at least partly
explained by the number of alternative substrates speci-
fied. Focusing on lipid metabolism, the median number
of reactions per EC number is three for EHMN, while
for HumanCyc, for example, the median is one. The
effect of alternative substrates has been noticed before
Table 5 Pathway database content statistics of core
metabolic processes
Number of (percentage of total)
Database Genes EC numbers Metabolites Reactions
BiGG 957 (64%) 558 (87%) 1041 (70%) 1301 (50%)
EHMN 1221 (49%) 707 (75%) 1924 (72%) 2180 (56%)
HumanCyc 832 (23%) 503 (41%) 847 (50%) 815 (46%)
KEGG 1291 (84%) 619 (85%) 1190 (77%) 1308 (80%)
Reactome 413 (36%) 279 (78%) 532 (54%) 511 (43%)
Genes: counts based on the internal database identifiers and including genes
encoding for a component of a protein complex as separate entities. EC
numbers: only fully specified EC numbers are counted. Metabolites: counts
based on the internal database identifiers and including instances of
metabolite classes for HumanCyc and members of sets for Reactome.
Reactions: if reactions only differ in direction and/or compartments they are
counted as one.
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Page 8 of 18[33] in a comparison of all reactions in BRENDA [34],
ENZYME [35], and KEGG. Reactions in these databases
overlapped for only 21%. Consensus increased to 67%
when they included only the main reactions, as defined
by IUBMB, of BRENDA and not the reactions derived
from these with alternative substrates.
Establishing identity
The difficulty of determining when databases refer to
the same compound partly explains the lack of overlap
on metabolite level and consequently on reaction level.
Metabolite identifiers provide a common ground for
finding corresponding metabolites in a reliable way, pro-
vided the correct identifier was assigned to each meta-
bolite. The only identifier type that is shared among the
five databases and that is available for a substantial
number of metabolites is the KEGG Compound ID
(Additional files 8 and 9). Unfortunately, for 34%
(HumanCyc) to 42% (BiGG) of the metabolites included
in the pathway databases, except for KEGG, this identi-
fier is missing. In KEGG for 8% of its metabolites the
KEGG Glycan ID is provided instead. To increase the
number of metabolites for which we could potentially
identify corresponding metabolites we also included
KEGG Glycan, ChEBI, PubChem and CAS IDs for the
comparison. However, 25% (HumanCyc) to 34% (BiGG)
of the metabolites included in the pathway databases
(except KEGG) were not linked to any of the four meta-
bolite databases (Additional file 9). We, therefore,
decided to also match on the metabolite name, which
has as disadvantage that there will often be a large
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Figure 3 Overlap between the five metabolic pathway databases for the comparison of the core metabolic processes. The dark green
bars give the percentage of entities (genes, EC numbers, metabolites and reactions) that are part of the consensus in the comparison restricted
to the following six categories: amino acid metabolism, carbohydrate metabolism, energy metabolism, lipid metabolism, metabolism of cofactors
and vitamins, and nucleotide metabolism. The majority score is given by the combined percentages of the dark green, light green (4 out of 5
databases agree) and yellow (3 out of 5) bars. The orange bars indicate the percentage of entities that can only be found in 2 databases. The
percentage of unique entities is indicated by the red bars. In matching the reactions we did not take into account e
-,H
+ and H2O.
Table 6 Statistics of the pathway database comparison of core metabolic processes
Number of (percentage of union)
Genes EC numbers Metabolites Reactions
union 1723 -55% 959 -32% 2805 -40% 3713 -47%
consensus 264 (15%) + 2% 180 (19%) + 1% 316 (11%) + 2% 144 (4%) + 1%
majority score 875 (51%) + 9% 508 (53%) + 3% 757 (27%) + 6% 674 (18%) + 4%
Database Unique per database (percentage of union)
BiGG 75 (4%) + 3% 63 (7%) + 4% 276 (10%) - 1% 621 (17%) - 1%
EHMN 186 (11%) + 8% 125 (13%) + 7% 910 (32%) + 7% 1129 (30%) + 4%
HumanCyc 70 (4%) -16% 62 (6%) -15% 243 (9%) - 7% 326 (9%) - 4%
KEGG 180 (10%) + 8% 45 (5%) + 4% 209 (7%) + 1% 274 (7%) + 2%
Reactome 19 (1%) - 3% 8 (1%) 0 80 (3%) - 6% 154 (4%) - 4%
Total 530 (31%) + 1% 303 (32%) 0 1718 (61%) - 6% 2504 (67%) - 3%
Genes: Entrez Gene IDs, including genes encoding for a component of a protein complex as separate entities. EC numbers: only fully specified EC numbers.
Metabolites: if two metabolites of one database both match the same metabolite in another database this is counted as one match. Reactions: reactions where
not required to match on e
-,H
+ and/or H2O. Differences with the outcomes of the global comparison (Table 3) are indicated in percentages for each level of
comparison.
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variants [36]. To restrict the possibility of false positive
matches caused by matching on the metabolite name,
we also required the chemical formula to match.
Even using this strategy, a large number of metabolites
without identifier remains that could not be matched on
name, see Additional file 10 for an overview. This over-
view shows that the majority of these unique metabo-
lites are part of specific metabolic processes, illustrating
t h ed i f f e r e n tc h o i c e sm a d eb ye a c ho ft h ed a t a b a s e s .I n
EHMN, for example, 60% of the unique metabolites
without an identifier are part of lipid metabolism. In
BiGG, 55% is found in glycan biosynthesis and metabo-
lism, e.g. precursors or degradation products of long
unbranched polysaccharides such as chondroitin sulfate,
heparin sulfate, or keratan sulfate. Furthermore, in Reac-
tome, 64% of the unique reactants without a metabolite
identifier are proteins and complexes directly encoded
b yt h eg e n o m ea n dh a v eaU n i P r o tI Di n s t e a d .I n
HumanCyc, finally, 55% of the metabolites are part of
reactions that have not been assigned to any pathway
and which are possibly peripheral to metabolism proper.
Restricting the comparison to the core metabolic pro-
cesses and removing macromolecular reactions from
Reactome and HumanCyc, reduced the impact of the
mismatches because of missing metabolite identifiers.
For BiGG, HumanCyc, and Reactome the percentage of
metabolites without an identifier decreased from 34%,
25%, and 31% to 21%, 13% and 10%, respectively (Addi-
tional file 11). Since lipid metabolism is part of the core
comparison, EHMN is still greatly affected by the lack
of identifiers for lipids and misses an identifier for 38%
of its metabolites. There is a large variety of lipids,
which may explain the lack of identifiers for this type of
metabolite.
On gene level the only identifier type shared by all five
databases is the Entrez Gene ID (Additional file 8). In
total 356 genes do not have an Entrez Gene ID (after
removing obsolete IDs) most of which are contained in
HumanCyc (327 genes). On the level of EC numbers the
five databases combined contain 83 EC numbers that
are not fully specified. Moreover, the catalysts of 41%,
27%, and 17% of the reactions in Reactome, BiGG and
EHMN, respectively, are not linked to an EC number.
In both cases this may be because IUBMB has not yet
assigned an EC number to the enzyme. For more than
half of these reactions not linked to an EC number in
BiGG, the catalyst facilitates a transport reaction. In this
case the Transport Classification (TC) system [37] of
the IUBMB might provide a more appropriate descrip-
tor. In EHMN and Reactome this is even 73% and 70%
of the cases, respectively. A number of EC numbers are
missing because the database curators did not enter
them into the database.
Miscellaneous
Next to the reasons outlined above, we also identified a
number of more subtle and less frequent explanations
for the limited overlap. An example at the metabolite
level is that BiGG uses D-glucose in its reactions instead
of specifying whether it is a-D-glucose or b-D-glucose,
while Reactome only uses a-D-glucose. The other data-
bases use all three variations. On the other hand, BiGG
does not use generic metabolites like ‘an alcohol’
(KEGG Compound ID: C00069) or ‘an L-amino acid’
(KEGG Compound ID: C00151) in contrast to Human-
Cyc, KEGG and EHMN. Furthermore, BiGG and
HumanCyc explicitly state that their reactions are
charge and mass balanced. The chemical formula and
charge of the metabolites were based on their ionization
state at a pH level of 7.2 and 7.3, respectively, while the
other three databases use the neutral form of the meta-
bolites. This partly explains the observed increase in
consensus when we did not take into account H
+.B y
using the KEGG Compound ID as the prime identifier
for matching metabolites, we reduce the impact of a dif-
ference in protonation state as in general the distinction
between the base and the acid form of a metabolite is
n o tm a d ei nK E G GC o m p o u n di nc o n t r a s tt o ,e.g.,
ChEBI. We also compared the databases while allowing
for an inexact match of the chemical formula with
respect to the number of H atoms, to account for the
variation in protonation state between the databases.
This hardly affected our results (data not shown).
Discussion
Our comparison revealed that there is only a small core
of the metabolic network on which all five databases
agree. Especially on reaction level the overlap is surpris-
ingly low, only 199 reactions could be found in all five
databases. Our analysis shows that the small overlap
between the databases is partly explained by conceptual
differences like a difference in coverage of the metabolic
network. One clear example is the large set of transport
reactions and reactions in lipid metabolism in EHMN,
which account for 23% of the unique reactions.
Our decision to compare five pathway databases, also
limits the consensus: the more databases one includes in
the comparison, the lower the consensus is likely to be.
We indeed observe a substantial increase in overlap
when we compare pairs of databases (Additional file 4)
instead of five. However, also in this case with a median
consensus of around 15%, the agreement on reaction
level is still relatively low. Two main factors can strongly
bias the size of the consensus detected. Firstly, the con-
sensus is constrained by differences in database size.
This partly explains, for example, the consensus of only
11% when comparing a large database such as EHMN
and a small database such as Reactome. Secondly, the
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bases are not constructed independently from each
other. For example, EHMN used KEGG as a starting
point for its reconstruction [9], which explains the
higher consensus of 28%. However, even if we would
restrict our comparison to three pathway databases,
BiGG, EHMN, and KEGG, that are most interdependent
[7,9], the consensus on reaction level is still only 14%,
when not considering the transport reactions from
BiGG and EHMN.
Despite the observed lack of overlap, the GO enrich-
ment analysis of the consensus and majority genes
(Additional file 2) does provide us with evidence that
there is a core of metabolic processes the databases
agree on. Examples of such processes are nucleotide
metabolism and carbohydrate metabolism, which is also
reflected on reaction level (Additional file 3). The com-
parison of the core metabolic processes indeed showed
a considerable increase of the majority score at the gene
level and to a lesser extent at reaction level. However,
the consensus on reaction level remains low even for
this more limited set.
Especially on reaction level the comparison is clouded
by several conceptual differences and technical difficul-
ties. The main technical challenge is to establish the
identity of metabolites between databases. This was also
observed to be one of the main problems for the experts
involved in the construction of the consensus of two in
silico metabolic network reconstructions of S. cerevisiae
[24]. Matching metabolites by name is not an ideal solu-
tion, as many, possibly ambiguous, synonyms and spel-
ling variants exist for the same metabolite [36].
Matching metabolites using metabolite identifiers is, in
our comparison, restricted by the relatively large num-
ber of metabolites that had not been linked any of the
four metabolite databases (KEGG, ChEBI, PubChem
Compound, and CAS). One reason for the lack of meta-
bolite identifiers is that the metabolite databases them-
selves are also work in progress. Metabolites that exist
in a large number of structural variations such as, for
example, lipids may not have been described yet in full
detail in the metabolite databases. This was indeed
observed for EHMN, where a large set of the unique
metabolites without an identifier is involved in lipid
metabolism. On the other hand, part of the metabolites
of the pathway databases may not be described in any of
the four metabolite databases we considered, because
they, for example, do not meet the criteria to be
included, such as proteins encoded by the genome
found in Reactome. Furthermore, all pathway databases
h a v eap r e f e r e n c ef o ro n eo ft h em e t a b o l i t ed a t a b a s e s
for which they curate the link. For example, BiGG
mainly derived its identifiers from KEGG Compound.
Similarly, for Reactome only ChEBI IDs have been
manually curated. Due to this, metabolites may not link
out to a metabolite database if the metabolite does not
exist in the preferred reference database.
It will require a considerable manual effort to cor-
rectly assign metabolite identifiers to each metabolite
and establish the correspondence of metabolites
between databases. An initiative that could aid in solving
some of these problems is ChemSpider [38], which inte-
grates a wide variety of metabolite databases. The use of
database-independent structural representations such as
SMILES and InChI strings has also been recommended
[24]. In our case, three databases (EHMN, HumanCyc
and KEGG) provide InChI strings for 77%, 58%, and
75% of their metabolites, respectively. The consensus is,
however, only 66 of the 3475 InChI strings in total. The
low consensus when matching on InChI string can
p a r t l yb ee x p l a i n e db yad i f f e r e n c ei nt h ea m o u n to f
detail with which the structure of metabolites has been
described and a difference in protonation state.
The question remains to what extent the reaction con-
sensus would increase, even if all metabolites were prop-
erly described. As illustrated by our comparison of the
TCA cycle also conceptual differences play an important
role in explaining the lack of overlap. A similar conclu-
sion can be drawn from a comparison of the two yeast
metabolic networks that were used in building a consen-
sus network [24]. Even after the identity of the metabo-
lites between the two reconstructions had been
established manually, the consensus on reaction level
was still only 36%. In a recent comparison of two meta-
bolic networks of A. thaliana [39] only 33% of the total
number of reactions could be matched unambiguously.
F u r t h e r m o r e ,i ti si m p o r t a n tt ok e e pi nm i n dt h a te v e n
if we would find unambiguous descriptions for each
metabolite this does not guarantee a match. Firstly, the
databases, or more specifically their metabolites, are
partly complementary. EHMN, for example, explicitly
focused on expanding lipid metabolism in comparison
to KEGG [9]. Secondly, many of the reactants without a
metabolite identifier are part of reactions that are per-
ipheral to metabolism proper, such as precursor and
degradation products of BiGG and proteins in Reac-
tome, and are therefore unlikely to have a match in all
five databases.
An example of a conceptual difference is the variation
in the number of intermediate steps used to describe a
specific metabolic conversion. This could be because of
different database-specific criteria for when the inter-
m e d i a t es t e p so fac o n v e r s i o ns h o u l db ed e s c r i b e do r
not. A second example is the use of generic metabolites
(e.g., alcohol) in reactions, as HumanCyc does. This may
be done to model the broad substrate specificity of the
enzyme or to indicate that the exact substrate specificity
is unknown. Other databases, for example BiGG, focus
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instead of alcohol. This difference may be amplified by
the number of specific instances given. Also more subtle
conceptual differences play a role, like a different proto-
nation state (neutral versus charged), the detail in which
the structure of a metabolite is described (e.g.,D - G l u -
cose versus a-D-Glucose) or whether the metabolite is
described as enzyme bound or not (e.g.,l i p o a m i d e - E
versus lipoamide). Finally, our GO enrichment analysis
showed that the scope of the metabolic networks
described by the five databases differs. The set of genes
that are only found in at most two databases is, com-
pared to the genes found in the majority of the data-
bases, enriched for terms related to protein metabolic
processes, like protein phosphorylation, proteolysis, and
RNA metabolism (Additional file 2). EHMN and
HumanCyc, for example, both include a generic reaction
describing the phosphorylation of a protein, which is
connected to a large set of 250 and 304 kinases, respec-
tively. Differences in the metabolic processes covered by
the databases also explain to some extent the differences
in size of the databases.
The differences mentioned above not only make it dif-
ficult to determine the consensus between databases,
but also to distinguish between conflicting and comple-
mentary content. This is especially so if one also keeps
in mind that all five databases are work in progress. For
example, a difference in the coverage of the metabolic
network could be caused by a fundamental disagreement
on whether certain processes are part of the human
metabolic network. It could also be that they just did
not include these processes yet and then this could be
seen as complementary information. Similarly, for 45%
of the consensus reactions the databases do not fully
agree on the genes coding for the catalyst (Additional
file 3), which may point to either complementary or
conflicting information. Another example is the differ-
ence in number of steps, which can in most cases be
explained by a difference in the level of detail of the
description. It could, however, also reflect disagreement
on the number of intermediate steps required for a par-
ticular conversion.
The low level of consensus provides compelling evi-
dence that additional curation and the integration of the
content of the five pathway databases in a single human
metabolic network is desir e da n dw o u l di m p r o v et h e
description of human metabolism. However, given the
results of our comparison and all difficulties outlined
above, what would be the way forward towards an inte-
grated network? The consensus consists of only 199
reactions, even less when also considering the connected
genes and EC numbers, and is therefore not of direct
practical use. Another option is to take the union of the
reactions contained in the individual databases. This is
the approach taken by, for example, ConsensusPathDB
[40] for integrating functional interactions, including
metabolic reactions. Besides being restricted by the
same conceptual and technical issues that we described,
combining the content of the databases is not the defi-
nite answer. It will not solve disagreements between
databases regarding, for example, the gene product cata-
lyzing a reaction or whether a reaction can take place in
human or not. Conflicting information would end up in
the union and ultimately requires manual curation or at
least annotation of such conflicts. Reasons for disagree-
ment are manifold and database-dependent. Some data-
bases, for example HumanCyc, prefer to err on the side
of false positives to bring potential pathways to the
attention of the community [11]. In BiGG, some reac-
tions without evidence were included because they
improved the performance of the in silico model. A dif-
ferent interpretation of the literature used in the con-
struction of the network also causes disagreements [24].
Moreover, some parts of the metabolic network are still
subject of debate and the current literature reflects these
different opinions. The union will for a large part con-
sist of data that is only supported by one of the
databases.
A third option is to only include reactions on which
the majority of the databases agree. This gives a higher
level of confidence and in our case also a considerably
larger set of 1004 reactions instead of the 199 reactions
in the consensus. However, caution is warranted as for
instance the databases are not strictly independent as
illustrated by our pairwise comparison of KEGG and
EHMN, for example. Erroneous data may, therefore, be
propagated in multiple databases. Our case study of the
TCA cycle also illustrates the problems of the majority
vote strategy (Additional file 12). If we retain all entities
the majority agrees on, 40% of the reactions are
included. However, the genes MDH1 and ACO1 encod-
ing for cytosolic proteins are also part of the majority as
is the conversion of citrate to oxaloacetate (EC 2.3.3.8),
which is also cytosolic. Moreover, there is no majority
for any of the EC numbers proposed by one of the data-
bases for the conversion of 2-oxoglutarate to succinyl-
CoA. Also conceptual differences can be observed as,
for example, we are left with two routes for both the
conversion of citrate to isocitrate. Furthermore, reac-
tions that are not part of the majority, but only found in
one or two databases are not necessarily incorrect, but
could be valuable complementary information. For
example, KEGG gives a more detailed description of the
conversion of 2-oxoglutarate to succinyl-CoA.
If the conceptual differences and technical issues we
identified would be resolved the overlap will increase. It
will, however, remain very difficult to (automatically)
discern useful complementary information from
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spread use of evidence codes indicating the type of evi-
dence supporting the data would enable to make a
distinction between high and low confidence data. How-
ever, extensive annotation of evidence is currently only
provided by BiGG and HumanCyc.
Significant manual intervention will be needed to
reach the ultimate goal of a single human metabolic net-
work. A promising model is a community-based
approach, such as WikiPathways [10] or an annotation
jamboree as advocated by Mo and Palsson [1]. A wiki-
based approach allows the community to curate existing
pathways and add new ones. Annotation jamborees are
organized around domain experts and facilitate the
reconciliation and refinement of metabolic pathway
databases. They have already been carried out success-
fully for various organisms [23-25]. The results of our
comparison could be used as a stepping stone for such
an effort as it is crucial to understand the underlying
causes of the differences to be able to resolve them. For
integration purposes, we also provide an automatically
derived overview of all reactions in which matching
reactions are aligned, along with their associated genes,
EC number and pathways (Additional file 13). The over-
views of the comparison on gene, EC number and reac-
tion level can be also found online http://www.molgenis.
org/humanpathwaydb. Here, results of the comparison
can be queried, sorted, and exported in a number of
ways. The web application was generated using the
MOLGENIS toolkit [41] and next to the graphical user
interface also provides several scriptable interfaces, e.g.,
an R interface. Using, for example, the majority reac-
tions as a starting point for curation these overviews
could aid experts on the human metabolic network to
consolidate the differences between the networks and
arrive at a unified model of human metabolism.
Conclusions
An accurate and complete reconstruction of the human
metabolic network is of utmost importance for its suc-
cessful application in the life sciences. Our results will
help curators to even further improve the metabolic net-
work as described in the individual databases. Further-
more, as our analysis shows, each of the five pathway
databases discussed in this paper provides us with a
valuable piece of the puzzle. Combining the expert
knowledge put into these five reconstructions and the
evidence provided will improve our understanding of
the human metabolic network. However, we explicitly
identified many issues that prohibit the (automatic) inte-
gration of the metabolic networks. Not only the unam-
biguous identification of metabolites is required but the
conceptual differences need to be addressed as well.
Considerable manual intervention and a broad
community effort are needed to reach the ultimate goal
of a consolidated and biologically accurate model of
human metabolism. Community efforts, such as BioPAX
[42] and SBGN [43], which standardize the representa-
tion of the pathway databases, could also aid the inte-
gration of the databases. Our detailed comparison of
five metabolic networks and the identification of the
conceptual differences between the databases provide a
stepping stone for their integration. The construction of
such an integrated network will, however, require con-
siderable time and effort. It would therefore be advisable
that users keep in mind, for now, the large differences
found and carefully weigh their decision when choosing
a particular database or if possible apply their analyses
to multiple networks to ensure the robustness of the
results.
Methods
Data retrieval
For each of the five pathway databases, we retrieved all
metabolic reactions with their corresponding gene(s),
EC numbers, and pathway(s). All files mentioned below
were downloaded in May, 2011.
For the metabolites we retrieved the following, most
frequently provided, types of identifiers, if available in
the specific pathway database (Additional file 8): KEGG
Compound http://www.genome.jp/kegg/compound/,
KEGG Glycan http://www.genome.jp/kegg/glycan/,
ChEBI http://www.ebi.ac.uk/chebi/, PubChem http://
pubchem.ncbi.nlm.nih.gov/, and CAS Registry Numbers
(proprietary, assigned by the CAS registry, http://www.
cas.org/). There are two types of PubChem IDs, Sub-
stance and Compound. Substance IDs are specific for
the depositor of the metabolite. Compound IDs unite
the different Substance IDs for the same metabolite. We
used the CID-SID file ftp://ftp.ncbi.nih.gov/pubchem/
Compound/Extras/CID-SID.gz to convert PubChem
Substance IDs to PubChem Compound IDs.
For genes we retrieved the Entrez Gene ID, which is
t h eo n l yt y p eo fg e n ei d e n t i f i e rt h ed a t a b a s e sh a v ei n
common (Additional file 8).
Syntactically incorrect and out-of-date identifiers
We manually corrected seven syntactically incorrect
KEGG Compound IDs and 50 KEGG Glycan IDs in
BiGG. We did the same for seven CAS IDs in BiGG and
one in HumanCyc. For the KEGG Compound, KEGG
Glycan, ChEBI and PubChem Compound IDs we
checked if the IDs were up-to-date (Additional file 1).
For the KEGG IDs we used the ‘compound’, ‘glycan’ and
‘merged_compound.lst’ file. For ChEBI we used its SQL
database ftp://ftp.ebi.ac.uk/pub/databases/chebi/gener-
ic_dumps/ and for PubChem the Batch Entrez from the
NCBI website http://www.ncbi.nlm.nih.gov/sites/batch-
entrez. We also checked and, when necessary, updated
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and ‘gene_history’ files from the FTP site ftp://ftp.ncbi.
nih.gov/gene/DATA/ of Entrez Gene. Finally, also the
EC numbers were updated using the ‘enzyme.dat’ file
downloaded from Expasy ftp://ftp.expasy.org/databases/
enzyme/. If an out-of-date metabolite ID, Entrez Gene
ID or EC number had been transferred, we replaced it
with the new one, and otherwise the ID or EC number
was not taken into account in the comparison.
BiGG
We downloaded the flat files containing reactions and
metabolites from http://bigg.ucsd.edu/ [44]. We
removed the 406 exchange reactions, indicated by the
prefix ‘EX-’, added to BiGG for simulation purposes.
Gene information was extracted from the SBML file.
W ei g n o r e dt h es u f f i xt h a tw a sa d d e dt ot h eE n t r e z
Gene IDs to discern transcript variants. We removed 38
reaction duplicates that only differed in their tissue
annotation. We raised the total percentage of metabo-
lites with an identifier from 53% to 66% by parsing the
HTML files of the metabolite pages available from the
BiGG website.
EHMN
We downloaded from http://www.ehmn.bioinformatics.
ed.ac.uk/ the EHMN Excel file containing sheets in
which the reactions are link e dt o :( i )p a t h w a y ( s )( i i )
genes, represented by an Entrez Gene ID, (iii) EC num-
ber(s). A separate file was provided to us by the curators
of this database containing information about the meta-
bolites including the five types of identifiers mentioned
above.
HumanCyc
We used Pathway Tools [45] to export the content of
HumanCyc into flat files. These were combined using
the internal Pathway Tools identifiers. We excluded two
signaling pathways, i.e.,t h e‘BMP Signalling Pathway’
and the ‘MAP kinase cascade’. HumanCyc uses classes
as substrates in some reactions (e.g.,a na m i n oa c i d ,a n
alcohol) as a way of catering for enzymes with broad
substrate specificity or enzymes for which the exact
substrate specificity is unknown. For the metabolite
comparison we retrieved the instances provided for
each metabolite class. There are 563 metabolite classes
that do not have instances, of which 192 have a meta-
bolite identifier, e.g.,aK E G GC o m p o u n dI D .T o
retrieve the identifiers for these metabolite classes we
used the Lisp API as they were not available in the
exported flat files. Finally, the Entrez Gene ID is missing
f o r6 0 5g e n e s .I fp r o v i d e d ,t h eE n s e m b lG e n eI Dw a s
mapped to an Entrez Gene ID, if available, via Ensembl
BioMart (181 genes). If both gene identifiers were
absent the UniProt ID was mapped to an Entrez Gene
ID via the UniProt ID Mapping service (101 genes).
After mapping an Entrez Gene ID was still missing for
323 genes and these were therefore not included in the
comparison. For 82% of this set all three IDs mentioned
are missing.
KEGG
We selected all human pathways from the metabolism
category. For each pathway, we downloaded from the
KEGG FTP site the human-specific KGML file, from
which we retrieved the genes, and the KGML file con-
taining the reference pathway linked to the EC numbers.
Entries in both files are numbered, which we used to
link genes to their associated EC numbers. In both files,
the catalyzed reaction can be found. A single entry can
contain more than one reaction, gene, and/or EC num-
ber. In that case, we assigned all genes and EC numbers
contained in the entry to each reaction. Note that we
cannot retrieve spontaneous reactions and reactions for
which the human gene encoding the catalyst is
unknown. Since KGML files only contain the main
metabolites of a reaction, we retrieved the complete
reaction from the flat ‘reaction’ file available on the FTP
site. We used the ‘H.sapiens.ent’ file to get the Ensembl
Gene IDs, and the ‘compound’ and ‘glycan’ files to
extract ChEBI, PubChem Substance, and CAS IDs for
metabolites.
Reactome
W eu s e dt h ed u m pf i l eo ft h eM y S Q Ld a t a b a s et o
retrieve data from Reactome. From the top-level path-
ways on the front page of the Reactome website, we
selected the ten pathways focused on (normal) metabolic
processes, excluding, e.g., signaling and disease-related
pathways (see Additional file 14 for a complete list). We
retrieved all reactions assigned to the selected metabolic
pathways. EC numbers were obtained from the table
that links catalyst activity to a GO term. Reactome con-
tains reactions operating on sets of metabolites. We
retrieved the instances of these sets from the MySQL
database dump. Following the description from the
Reactome Curator Guide http://wiki.reactome.org/index.
php/Reactome_Curator_Guide we instantiated the reac-
t i o n sb yt a k i n gt h ef i r s tm e m b e ro ft h es e ta tt h el e f t
h a n ds i d ea n dt h ef i r s tm e m b e ro ft h es e ta tt h er i g h t
hand side, and so on. In five cases this was not possible
and we, therefore, did not instantiate the sets in these
five reactions. Two examples are shown in Additional
file 15. Reactome’s black box events represent reactions
for which the molecular details are not specified or
unknown. We excluded a black box event if the input
or output of the reaction was unknown.
TCA Cycle
Two EC numbers only mentioned in the comment field
of the SBML file of BiGG were also taken into account.
We left out the transport reactions that EHMN included
in this pathway as KEGG does not contain any transport
reactions in its metabolic network.
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We compared five metabolic pathway databases at dif-
ferent levels: genes, EC numbers, metabolites, reactions,
and relations between these components. Below, we
describe in detail how we compared each of these
components.
Genes
For the primary comparison at gene level we used
Entrez Gene IDs, since it is the only gene identifier
common to all five databases. BiGG, HumanCyc, and
Reactome provide syntactic mechanisms for defining
protein complexes, while EHMN and KEGG do not.
Therefore, we did not make a distinction in the compar-
ison between genes encoding a component of a catalyst
or genes that encode a single protein catalyst.
EC numbers
A fully specified EC number consists of four numbers
separated by a period [27]. The first three numbers indi-
cate increasingly narrower classes and the fourth num-
ber is the serial number of the enzyme in its subclass.
The databases combined contain 83 partial EC numbers,
such as 1.1.1.-, which were excluded from the compari-
son, since they are semantically ambiguous [46].
Metabolites
Establishing identity between metabolites is a challen-
ging task. For the comparison we, in general, used the
KEGG Compound ID, which is in each database the
most frequently provided metabolite identifier. However,
KEGG Compound IDs are not available for each meta-
bolite (Additional file 9). If the KEGG Compound ID
was not provided, metabolites were matched on any of
the other metabolite identifiers (KEGG Glycan, ChEBI,
PubChem Compound or CAS) or metabolite name, in
the latter case we also required an exact match of the
chemical formula. Matching was case-insensitive and
spaces and punctuation in the metabolite names were
ignored. Furthermore, we computed the transitive clo-
sure of the metabolite matches. This means that if for a
particular metabolite there was a match between data-
base A and B, e.g., on CAS ID, and between database B
and C on, e.g., ChEBI ID then the metabolite was con-
sidered to match between database A and C as well.
Instances of metabolite classes in HumanCyc and mem-
bers of sets in Reactome were included in the compari-
son at metabolite level. To make the comparison as
accurate as possible we did not match more generic
metabolites, like alcohol or glucose, with more specific
metabolites, like ethanol or a-D-glucose.
Reactions
We considered reactions to be the same if all substrates
and products matched (see above). The direction of a
reaction was not taken into account in the comparison.
The same reaction written in two directions was
counted as one reaction. Compartment(s) were not
considered as well. We again took the transitive closure
for the reaction matches (see above).
TCA cycle
In our detailed comparison of the TCA cycle, the fol-
lowing three pairs of metabolites were considered to
match despite not having the same KEGG Compound
ID: s-succinyldihydrolipoamide-E and s-succinyldihydro-
lipoamide; lipoamide-E and lipoamide; dihydrolipoa-
mide-E and dihydrolipoamide. The only difference
between these pairs is that one is the enzyme bound
form of the metabolite, e.g., lipoamide-E, and the other
is indicated as being unbound, e.g., lipoamide. The reac-
tions were compared while not taking into account H
+.
In contrast to the comparison of the entire networks we
removed neither the obsolete Entrez Gene IDs nor the
gene for which the Entrez Gene was not available at all.
Gene ontology analysis
Differences in GO biological process annotation
between two lists of genes were assessed with the
FatiGO functional enrichment module of the Babelo-
mics suite (version 4.2, http://babelomics.bioinfo.cipf.es/)
FatiGO uses the Fisher’s exact test for 2 × 2 contingency
tables to check for significant over-representation of GO
biological process terms (levels 3-9) in one of the sets
with respect to the other one. We used the default set-
tings except that we set the filter for the minimum and
maximum number of annotated IDs per term to 1 and
10000, respectively. GO terms were considered to be
significantly over-represented if the p-values, adjusted
for multiple testing by using Benjamini and Hochberg’s
method, were <0.01.
Grouping pathways into categories
For the comparison of the core metabolic processes, we
manually assigned the pathways of each database to one
of the following nine categories using the division of
KEGG as a guideline: amino acid metabolism, carbohy-
drate metabolism, energy metabolism, glycan biosynth-
esis and metabolism, lipid metabolism, metabolism of
cofactors and vitamins, metabolism of secondary meta-
bolites, nucleotide metabolism, and xenobiotics biode-
gradation and metabolism (Additional file 7). Pathways
that did not fit in any of these nine KEGG categories
were assigned to the category ‘Miscellaneous’. Transport
reactions of BiGG, EHMN, HumanCyc and Reactome
were assigned to a separate category. A reaction was
considered a transport reaction if not all metabolites
were localized in the same compartment. Most transport
reactions in BiGG and Reactome were originally already
assigned to separate transport pathways by the databases
themselves. Reactions that were not assigned to any
pathway could not be assigned to any category. Note
that reactions, EC numbers and genes may be found in
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multiple categories.
Additional material
Additional file 1: Transferred and obsolete identifiers and EC
numbers per database. Number of transferred and obsolete EC
numbers, gene and metabolite identifiers for each of the five pathway
databases.
Additional file 2: Results of the FatiGO analyses. GO biological
processes enriched according to FatiGO for the following comparisons:
WS1) genes in the consensus on gene level versus the union of the
remaining genes, WS2) all unique genes versus the union of the
remaining genes, WS3-WS7): unique genes per database (BiGG, EHMN,
HumanCyc, KEGG, Reactome) versus the remaining genes contained in
the union, WS8) genes contained in the majority of the databases versus
the union of the remaining genes.
Additional file 3: Consensus reactions. Overview of the reactions part
of the consensus of all five pathway databases (when not taking into
account e
-,H
+ and H2O). For each consensus reaction the corresponding
EC numbers, genes (Entrez Gene IDs), and pathways are also given for
each database.
Additional file 4: Pairwise comparison of the five databases on
gene, EC, metabolite, and reaction level. Consensus between pairs of
databases is calculated as in the main text: (|CDB1 ∩ CDB2|/|CDB1 ∪ CDB2|) ×
100%, where C is the set of entities under consideration. Databases are
compared on Entrez Gene IDs, EC numbers, metabolites, and reactions,
which were not required to match on e
-,H
+ and/or H2O.
Additional file 5: TCA cycle as represented in each of the five
metabolic pathway databases. Adapted version of Figure 2 in the
main text for each of the metabolic pathway databases separately.
Reactions occurring in the TCA cycle for the selected database are
highlighted. Metabolites are represented by rectangles, genes by
rounded rectangles, and EC numbers by parallelograms. Color indicates
how many of the five databases include a specific entity. Color of an
arrow indicates the number of databases that agree upon an entire
reaction, i.e., all its metabolites (except H
+ which was matched
separately). ‘x’ denotes a missing EC number.
Additional file 6: TCA cycle as represented in each of the five
metabolic pathway databases. Breakdown of the TCA cycle per
database. WS1) Overview of all reactions, plus corresponding EC numbers
and genes. WS2) Reactions of each database; matching reactions are
aligned. For reactions that are not part of the TCA cycle consensus an
explanation for the differences observed is given in column B (see also
section ‘Analysis of differences between databases’ in the main text).
WS3) Metabolites of each database; matching metabolites are aligned.
WS4) EC numbers of each database; matching EC numbers are aligned.
WS5) Genes of each database; matching genes are aligned. In WS3-WS5
metabolites, EC numbers, and genes are matched across the entire TCA
cycle.
Additional file 7: Grouping of pathways into categories. Overview of
the manual grouping of pathways of each database into one of eleven
categories, see Materials and Methods.
Additional file 8: Identifier types for genes and metabolites present
in each of the databases.
Additional file 9: Metabolite counts per database. For each of the
five databases the percentage of metabolites without a chemical formula
and the percentage of metabolites without an identifier is indicated.
Furthermore, for each pathway database the percentage of metabolites
linked to a particular metabolite database (KEGG Compound, KEGG
Glycan, ChEBI, PubChem Compound, and CAS) is indicated. We also
included the instances of metabolite classes for HumanCyc and
members of sets for Reactome, see Materials and Methods.
Additional file 10: Names of metabolites without a match in any of
the four other databases and without any of the five types of
metabolite identifiers.
Additional file 11: Metabolite counts per database for the
comparison of core metabolic processes. For the metabolites of the
core metabolic processes in each of the five pathway databases the
percentage of metabolites without a chemical formula and the
percentage of metabolites without an identifier is indicated. Furthermore,
for each pathway database the percentage of metabolites linked to a
particular metabolite database (KEGG Compound, KEGG Glycan, ChEBI,
PubChem Compound, and CAS) is indicated. We also included the
instances of metabolite classes for HumanCyc and members of sets for
Reactome, see Materials and Methods.
Additional file 12: TCA cycle: majority vote. Adapted version of Figure
2 in the main text when retaining only the entities that at least three out
of five databases agree on. Reactions occurring in the majority are
highlighted. Metabolites are represented by rectangles, genes by
rounded rectangles, and EC numbers by parallelograms. Color indicates
how many of the five databases include a specific entity. Color of an
arrow indicates the number of databases that agree upon an entire
reaction, i.e., all its metabolites (except H
+ which was matched
separately).
Additional file 13: Overview of all reactions and their matches.
Overview of all reactions and their matches (when not taking into
account e
-,H
+ and H2O). Rows are colored according to the number of
databases that agree on a reaction. For each reaction the corresponding
EC numbers, genes (Entrez Gene IDs), and pathways are also given for
each database.
Additional file 14: Top-level pathways from Reactome (not)
considered in the comparison.
Additional file 15: Instantiating reactions containing sets of
metabolites. Reactome contains reactions defined in terms of sets of
metabolites. For five of such reactions the specific instantiations could
not be derived automatically, this document gives two detailed
examples.
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